Iqbal, Sajid; Sabbour, Hani Mohamed; Ashraf, Tanveer; Santos Filho, Raul Dias dos 
; Buckley, Adam
Source: Clinical therapeutics. Unidade: FM
Subjects: HIPERCOLESTEROLEMIA, INFLAMAÇÃO, FÁRMACOS (SISTEMA CARDIOVASCULAR), PREVENÇÃO DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
IQBAL, Sajid et al. First report of inclisiran utilization for hypercholesterolemia treatment in real-world clinical settings in a middle east population. Clinical therapeutics, v. 46, n. 3, p. 186-193, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/76867. Acesso em: 25 jan. 2026.APA
Iqbal, S., Sabbour, H. M., Ashraf, T., Santos Filho, R. D. dos, & Buckley, A. (2024). First report of inclisiran utilization for hypercholesterolemia treatment in real-world clinical settings in a middle east population. Clinical therapeutics, 46( 3), 186-193. doi:10.1016/j.clinthera.2023.12.003NLM
Iqbal S, Sabbour HM, Ashraf T, Santos Filho RD dos, Buckley A. First report of inclisiran utilization for hypercholesterolemia treatment in real-world clinical settings in a middle east population [Internet]. Clinical therapeutics. 2024 ; 46( 3): 186-193.[citado 2026 jan. 25 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76867Vancouver
Iqbal S, Sabbour HM, Ashraf T, Santos Filho RD dos, Buckley A. First report of inclisiran utilization for hypercholesterolemia treatment in real-world clinical settings in a middle east population [Internet]. Clinical therapeutics. 2024 ; 46( 3): 186-193.[citado 2026 jan. 25 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76867
